Driven by a confluence of favorable policies, rising demand quality, upgrading manufacturing capabilities, technological innovation, and capital investment, the medical-device industry has emerged as the fastest-growing segment within the health-care sector and one of the most promising investment hotspots in the capital markets. According to forecasts by the China Pharmaceutical Industry Information Center, the size of China’s medical-device market is expected to exceed RMB 600 billion in 2019, with a projected compound annual growth rate of 16.8%. Looking ahead, innovation will be the primary engine of rapid growth in the medical-device market and the fundamental solution for advancing supply-side structural reform; China’s medical-device innovation has now entered a golden decade.

　　1. How Investment Firms Can Seize the Opportunities of the Golden Decade

　　For investment firms, navigating the highly diversified medical-device industry and fully capitalizing on the golden decade of innovation presents a significant challenge—particularly for those new to the sector. On the one hand, opportunities appear abundant yet fragmented; on the other, market potential in many segments seems limited, even as some seemingly niche areas are delivering strong growth. So, amid such a wide array of sub-sectors, how can investors effectively identify and seize the right opportunities?

　　There is no shortcut to solving this problem; it can only be assessed from three perspectives: first, the size and sustained growth potential of the specific sub-sector in which the project operates; second, the innovativeness of the project’s core product, its disruptive clinical applications, and the resulting leading market opportunities; and third, the founding team and management. The first two dimensions can only be clearly understood and validated through systematic industry research. We have categorized medical devices into seven sub-sectors: in vitro diagnostics, imaging, cardiovascular and cerebrovascular, surgical and orthopedic, oncology, medical artificial intelligence, and other general-purpose categories. We have conducted thorough, systematic research across these sub-sectors, mapping nearly every significant player in each, continuously monitoring and updating developments, and promptly following up with investment. The benefit of this approach is that we gain a comprehensive and in-depth understanding of progress within each sub-sector, systematically track high-performing companies, and are thus able to assess the first two dimensions with confidence and precision, targeting our investments effectively.

Keysee